| November 3, 2016 (Thursday) | ||||
|---|---|---|---|---|
| 13:00-14:00 | Council Meeting | |||
| 13:30-14:30 | Registration | |||
| 14:40-15:00 | Opening Ceremony | |||
| 15:00-15:45 |
Plenary Lecture 1 Mukunghwa Hall (2F)Protective Roles of Translational Machinery against Genotoxic Stresses Chaired by Dr. Young-Jin Chun (Joong-Ang University) TBA Dr. Sung Hoon Kim (Seoul National University) |
|||
| 15:45-16:00 | Coffee Break / * Poster Session | |||
| 16:00-17:30 |
Session 1 Mokryen Hall (1F)Adverse Outcome Pathways: From Science To Regulation Chaired by Dr. Seokjoo Yoon |
Session 2 Mukunghwa Hall (2F)Genotoxicity and Therapeutic Targets in Cancer Chaired by Dr. Hye Kyung Na |
||
| 16:00-16:35 The Adverse Outcome Pathway (AOP) Concept: Introduction, Background and Principles Dr. Mark Cronin (Liverpool John Moores University, UK) 16:35-17:10 Perspectives on How the Adverse Outcome Pathway Concept Informs the Use of in vitro Developmental Neurotoxicity (DNT) Data for Regulatory Purposes Dr. Anna Bal-Price (EURL, Italy) 17:10-17:30 AOP Activities and Case Study of KIT Dr. Daeui Park (Korea Institute of Toxicology) |
16:00-16:30 Indolequinones mediates atypical degradation of PARP-1 and induce controlled necrosis in chronic myeloid leukemia Dr. Marc Diedrich (Seoul National University) 16:30-17:00 RSK2 as a Novel Molecular Target in Human Cancer Dr. Yong-Yeon Cho (The Catholic University of Korea) 17:00-17:30 The in vivo Pig-a Assay for Genotoxicity Evaluation Dr. Young-Shin Chung (Hoseo University) |
|||
| 17:30-18:00 | General Assembly | |||
| 18:00 | Reception | |||
| November 4, 2016 (Friday) | ||||
|---|---|---|---|---|
| 09:15-10:00 |
Plenary Lecture 2 Mukunghwa Hall (2F) |
|||
| 10:00-10:20 | Coffee Break | |||
| 10:20-11:50 |
Session 3 Mukunghwa Hall (2F)Antimutagenicity and Anticarcinogenicity Chaired by Dr. Donghak Kim (KonKuk University) |
|||
| 10:20-10:50 Inhibition of Carcinogen-Activating Cytochrome P450 by Xenobiotics in Relation to Anti-carcinogeneis and Anti-mutagenesis Dr. Tsutomu Shimada (Osaka Prefecture University, Japan) 10:50-11:20 Hereditary Cancer and Germ Line DNA Mutation Dr. Wonshik Han (Seoul National University) 11:20-11:50 A Novel Facet of Bcl-2: Regulation of Redox Stress-induced DNA Damage in Cancer Cells Dr. Shazib Pervaiz (YLL School of Medical National University, Singapor) |
||||
| 11:50-13:30 | Lunch / * Poster Session | |||
| 13:30-15:30 | Session 4 Mukunghwa Hall (2F)Development of OECD TG Chaired by Dr. Soojung Sohn |
Session 5 Mokryen Hall (1F)New Advances in Biological Monitoring for Occupational Health Chaired by Dr. Boo-Hyon Kang (Chemon.Inc,) |
||
|
14:00-14:30 International Current Status on the Development of Toxicity Testing Methods for Nanomaterials Dr. Jun-young Yang (National Institute of Food and Drug Safety Evaluation) 14:30-15:00 Current Status and Future Plan for Development of OECD EDCs Testing and Assessment Methods in Korea Dr. HeeSeok Lee (National Institute of Food and Drug Safety Evaluation) 15:00-15:30 Development of an Alternative Test Method for the Local Lymph Node Assay Using Flow Cytometry Dr. Jung-Sun Yi (National Institute of Food and Drug Safety Evaluation) |
13:30 ~ 14:10 New Trends of Occupational Toxicity and the Role of Inhalation Toxicity Dr. Jun Kanno (Bioassay Research Center, Japan) 14:10 ~ 14:50 AAALAC International Standards and Accreditation Process Dr. Leslie Retnam (Biological Resource Centre, Singapore) 14:50 ~ 15:10 Interpretation and Evaluation of Carcinogenecity Study Dr. Bum-Seok Han (Hoseo University) 15:10 ~ 15:30 Harzard Assessment Using Inhalation Dr. Yong-Soon Kim (Korea Occupational Safety and Health Agency) |
|||
| 15:40-16:10 | Award Presentation / Closing Remarks | |||
Date : Nov. 3 (Thu) ~ 4 (Fri), 2016
Venue : Samsung Convention Center, Seoul National University, Korea
Theme : Progress in Studies on the Antimutagenicity and Anticarcinogenicity
Deadline For Early Registration: October 21 , 2016
Deadline for abstract submission : October 21 , 2016’